Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MS4A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HDAC6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
THOC5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD23 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTAGE5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCM3AP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01000 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RBM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF844 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SYMPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RANBP10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on